Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 3
Submit an article Journal homepage
247
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Trends in myeloma relative survival in Queensland by treatment era, age, place of residence, and socioeconomic status

Matthew HarwoodDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Australia;
,
Nathan DunnQueensland Cancer Control Analysis Team, Queensland Health, Brisbane, Australia;
,
Julie MooreQueensland Cancer Control Analysis Team, Queensland Health, Brisbane, Australia;
,
Peter MolleeDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Australia; ;University of Queensland, Brisbane, Australia
&
Greg HapgoodDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Australia; ;University of Queensland, Brisbane, AustraliaCorrespondence[email protected]
Pages 721-727 | Received 08 Sep 2019, Accepted 25 Oct 2019, Published online: 14 Nov 2019

References

  • Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). Lyon: International Agency for Research on Cancer; 2017.
  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:538–548.
  • Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015;33(26):2863–2869.
  • Alexanian R, Haut A, Khan AU, et al. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. JAMA. 1969;208(9):1680–1685.
  • Myeloma Trialists’ Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. J Clin Oncol. 1998;16:3832–3842.
  • Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med. 1996;335(2):91–97.
  • Pulte D, Jansen L, Castro FA, et al. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. 2015;171(2):189–196.
  • Costa LJ, Brill IK, Omel J, et al. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Adv. 2017;1(4):282–287.
  • Thorsteinsdottir S, Dickman PW, Landgren O, et al. Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study. Haematologica. 2018;103(9):e412–e415.
  • Andres M, Feller A, Arndt V. Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013. Cancer Epidemiol. 2018;53:105–110.
  • Yu XQ, Chen WH, O’Connell DL. Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia. BMC Cancer. 2010;10(1):231.
  • Chen TY, Morrell S, Thomson W, et al. Survival from breast, colon, lung, ovarian and rectal cancer by geographical remoteness in New South Wales, Australia, 2000–2008. Aust J Rural Health. 2015;23(1):49–56.
  • Yu XQ, Luo Q, Smith DP, et al. Geographic variation in prostate cancer survival in New South Wales. Med J Aust. 2014;200(10):586–590.
  • Ho-Huynh A, Tran A, Bray G, et al. Factors influencing breast cancer outcomes in Australia: a systematic review. Eur J Cancer Care (Engl). 2019;28(4):e13038.
  • Loberiza FR Jr, Cannon AJ, Weisenburger DD, et al. Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study. J Clin Oncol. 2009;27(32):5376–5382.
  • Baade PD, Yu XQ, Smith DP, et al. Geographic disparities in prostate cancer outcomes – review of international patterns. Asian Pac J Cancer Prev. 2015;16(3):1259–1275.
  • Riba LA, Gruner RA, Alapati A, et al. Association between socioeconomic factors and outcomes in breast cancer. Breast J. 2019;25(3):488–492.
  • Lundqvist A, Andersson E, Ahlberg I, et al. Socioeconomic inequalities in breast cancer incidence and mortality in Europe – a systematic review and meta-analysis. Eur J Public Health. 2016;26(5):804–813.
  • Fiala MA, Finney JD, Liu J, et al. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma. Leuk Lymphoma. 2015;56(9):2643–2649.
  • Australian Bureau of Statistics. Australian Standard Geographical Classification (ASGC). Updated June 2014. [cited 2019 May]. Available from: http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Australian+Standard+Geographical+Classification+(ASGC).
  • Australian Bureau of Statistics. Socio-Economic Indexes for Areas. Updated March 2018. [cited 2019 May]. Available from: http://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa.
  • Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations (Methodological Note No. 10). Bethesda (MD): End Results Evaluation Section, National Cancer Institute; 1959.
  • Australian Bureau of Statistics. 3235.0. Population by age and sex, regions of Australia, 2015. August 2016. [cited 2019 May]. Available from: http://www.abs.gov.au/AUSSTATS/[email protected]/DetailsPage/3235.02015?OpenDocument.
  • Esteve J, Benhamou E, Croasdale M, et al. Relative survival and the estimation of net survival: elements for further discussion. Statist Med. 1990;9:529–538.
  • Dickman PW, Sloggett A, Hills M, et al. Regression models for relative survival. Statist Med. 2004;23(1):51–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.